NL-OMON36291已完成不适用
An Evaluation of the Safety and Pharmacokinetics of Posaconazole (POS, SCH 56592) IV Solution via Peripheral Administration in Healthy Volunteers (P06356) - P06356
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Merck
- 入组人数
- 96
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Healthy male and female
排除标准
- •Clinical significant abnormalities at medical research
研究者
相似试验
进行中（未招募）
1 期
P06356EUCTR2010-020832-20-NLSchering-Plough Research Institute, a Division of Schering Corporation - for Global trials96
尚未招募
1 期
Safety and pharmacokinetics of CIGB-552Solid tumorsRPCEC00000196Center for Genetic Engineering and Biotechnology (CIGB)
已完成
不适用
A Safety, Tolerability and Pharmacokinetic Study of Single and Multiple Doses of LY3526318 in Healthy ParticipantsNL-OMON50998Eli Lilly16
进行中（未招募）
1 期
Safety, Tolerability and Pharmacokinetics of Tirzepatide in Pediatric Participants with Obesity.Weight managementMedDRA version: 20.0Level: HLTClassification code 10027428Term: Metabolic disorders NECSystem Organ Class: 100000004861EUCTR2024-000081-22-Outside-EU/EEAEli Lilly and Company
招募中
1 期
Phase 1 study of 211At-MABG in patients with pheochromocytoma/pargangliomaPheochromocytoma, paragangliomaD010673, D010235JPRN-jRCT2021220012Shiga Tohru18